The aim of this study was to compare the effect of different treatment in cat models of induced nutritional secondary hyperparathyroidism (NSHPT) by using chicken's eggs hell compared to other conventional treatments. The NSHPT was induced experimentally in 20 rapidly growing kittens by feeding a diet consisted of only beef heart meat (low Ca-high P) for 9weeks. The clinical signs of NSHPT in kittens included disturbance in locomotion manifested by reluctance to move, posterior lameness, and uncoordinated gait. The diseased kittens were divided into four equal groups (n=5), each group was treated with a different protocol. Treatment of affected kittens was achieved by eggshell (G4) that was compared to three treatment protocols including combined Cavitamin D injection. (G1), oral Ca alone (G2) and oral Ca, Mg, and Zn (G3). The clinical symptoms and biochemical analysis were monitored at day 1, 3, 5 and 7 after treatment. The PTH and 1.25 (OH) 2 Vit.D3were gradually reduced starting from the 1 st day post treatment in eggshell treated group compared to other treatment groups. The eggshell treatment induced changes in clinical signs and biochemical parameters that were comparable to the other three groups. Based on these results, it was suggested that feeding egg shell solution could be used as an economic source of Caasan alternative treatment for NSHPT in cats.
(http://www.bvmj.bu.edu.eg) (BVMJ-34(1): 182-194, 2018) 1. INTRODUCTION:
Nutritional secondary hyperparathyroidism (NSHPT) is caused by chronic hypocalcaemia due to persistent deficiency of calcium in diet (Williams 2007) . NSHPT is a generalized metabolic bone disease characterized by osteopenia and caused by inadequate calcium in the diet, excessive phosphorus, or a combination of both (Nap and Hazewinkel,1994) and (Moarrabi et al.,2008) . The most common cause of NSHPT is dietary insufficiency of calcium or vitamin D and excess phosphorus (Phillips et al., 2011) . The clinical manifestations of NSHPT in kittens are anorexia, weight loss, depression, hyperesthesia, constipation, joint pain and lameness. In advanced cases the neck becomes rigid due to ankylosis of the cervical vertebrae, lameness in the forelimb and pain owing to nerve root compression. Kittens with NSHPT were stunted and have limb deformity (Scott and Meloughlin,2007) . The short-term parenteral calcium gluconate injection, a balanced diet and cage rest were the treatment of cats with NSHPT (Tomsa et al (1999) and Aldavood et al., (2009) . The conventional treatment consisted of intravenous administration of calcium in the form of 10% calcium gluconate (5-15 mg / kg) given slowly over 10-30 minutes that give the effect immediately beside that oral supplementation with vitamin D and calcium is needed (Lappin 2001) . Calcium carbonate represents 95% of chicken eggshell and 3.5% is organic mixtures. The chicken eggshell which is rich in calcium carbonate was used in treatment of calcium deficiency in human and animals (Daengprok et al 2003) . The weight of one eggshell is 6 grams that contained 2200 mg of calcium (Vlad, 2009 ). The treatment of hypocalcaemia by using of 10% calcium gluconate could be disadvantageous because it may be accompanied by bradycardia (Scott et al 2014) . Therefore, the treatment of NSHPT by oral Ca carbonate and vit D was proposed (Asiet al 2014) .
In this study, we used the eggshell as a natural therapy for cats with experimentally induced NSHPT and compare the result with other treatment protocols including combined Ca and Vit. D injection, oral Ca alone and oral Ca, Mg and zinc.
MATERIALS AND METHODS:

Animals and experimental design
The present study was carried out on 20 apparently healthy male kittens aged from 2 to 3months, and their body weight ranged between 0.45-0.85 kg. All the 20 male kittens were experimentally induced with NSHPT by feeding a diet of only beef heart. Iodine was added to maintain healthy thyroids and tap water was supplied ad-libitum according to the method described by Rowland et al (1968) . This diet induced the NSHPT after feeding for 9 weeks. After complete induction of NSHPT in young male cats that ended on the 9 th week of induction that considered the zero days (0-day) of the beginning of t re at m en t t ri al s, t h e 20 ki t t ens w e re randomized into 4 groups, each group was treated with a different treatment protocol. The first group (G1) (5mg) and cholecalciferol 0.2mg (500,000 I U/g) (100 IU). The fourth group (G4) was treated by eggshell solution prepared from eggshell powder as described later. The clinical and biochemical results were recorded from the 0-day, 1 st day, 3 rd day, 5 th day and e n d e d o n t h e 7 th d a y o f t r e a t m e n t .
Preparing of eggshell powder and solution 2.2.1. Eggshell powder
Eggshell was dried in the sun or oven on the sheet for baking for 5 minutes to dry then ground in the grinder to get the powder of eggshell according to method of Brunet al.
( 2 0 1 3 ) .
Egg shell solution
One teaspoon of eggshell powder (equivalent to 2000-3000 mg Ca) was dissolved in 20 ml of milk then boiled and allowed to cool down. The eggshell solution was given orally once daily for 7 days. (The Weight of one eggshell equal six grams that contained 2200mg of calcium.).The dose used was 1 Eggshell powder /orally /day for 7 d a y s ( B i o v a , 2 0 0 9 ) .
Clinical examination
The Kittens were subjected to clinical examination and all clinical signs were recorded before and after treatment as previously described (Kelly, 1984) .
2.4.Biochemical analysis 2.4.1.Blood samples
Blood samples were collected from cephalic or jagular vein according to Kirk and Bistner (1985) . The blood samples (5ml) were divided into two portions, one with anticoagulant (potassium salt of EDTA) for hematological examinations and the other portion without anticoagulant for obtaining a clear non hemolyzed serum by centrifugation of the blood sample at 3000 r.p.m. for 5 minutes. The clear sera were aspirated carefully by automatic pipette and transferred into clean dry labeled Eppendorf tubes, and stored at −20°Ctill examination. Only clear non hemolyzed serum was used. Special chemical kits (Produced by Bio-analytic Company, Egypt) were used for determination of serum parathyroid hormone (PTH), 25-hydroxyvitamin D3, 1, 25-di hydroxyvitamin D3, BUN, creatinine, creatinine phosphokinase (CPK), alkaline phosphatase (ALP), calcium (Ca), phosphorus, copper (Cu), zinc (Zn) ,magnesium (Mg) , total protein (TP) ,albumin (Alb) and globulin (glob) were determined at 0-day, 1 st day, 3 rd day, 5 th day and 7 th day of treatment according to method described by Tomsa et al (1999) .
Statistical analysis
Statistical analysis of results was carried out using two ways analysis of variance (ANOVA) with Duncan's post hoc test as previously described (Bailey,2008) using sigma stat software to test both treatment and times effect. The results were demonstrated as means ± SE. The results were considered statisticall y si gni ficant when p<0.05.
RESULTS:
3. Treated cats developed normal defection and ability to stand and move. While cats of G2 showed gradual improvement of movement, and ability to stand and move after one to four days. Defection improved on the 3 days post of treatment but joint pain and lameness improved on the 7 day of treatment.
Cats in group BP3 showed gradual improvement of movement, and ability to stand and move after one to three days. Defection improved after the4 th days but joint pain and lameness improved from day 7 of treatment. Cats in G4 showed gradual improvement of movement, and ability to stand and move after three to four days. Defection improved 3 days aftertreatment but joint pain and lameness improved from the 6 th day of treatment (Fig,1, 2) .
Serum biochemical changes:
The obtained data in table 1 showed symptoms of decrease in serum parathyroid hormone (PTH) and 1,25 (OH)2 Vit.D3 beginning from the 1 st day of treatment in all groups of treatment with only significant (P<0.05) decrease in the first group of treatment (G1) than the other three groups. There were non-significant changes between groups on the other periods of treatment. On the other hand, serum 25 (OH) Vit.D3 revealed a significant (P<0.05) increase from the 1 st day of treatment with no significant changes observed among groups.
The data presented in table 2 demonstrated that, serum CPK activity revealed significant (P<0.05) decrease from the 1 st day of treatment in all groups of treatment with only significant (P<0.05) decrease in the first group than the other groups of treatment. Serum ALP activity revealed a significant (P<0.05) decrease from the 1 st day of treatment in all treatment groups with no significant changes observed between them all over the period of treatment.
The data demonstrated in table 3 revealed that serum total protein confected significantly (P<0.05) increased from the 3 rd day of treatment in all treatment groups with no significant changes among groups all over the period of treatment. On the other hand, serum albumin level result was significantly (P<0.05) increased from the 3 rd day of treatment in the first group but from the 1 st day of treatment in the other groups of treatment. Serum globulin was showed a significant (P<0.05) increase in the first and fourth groups of treatment (from the 1 st to 7 th day of treatment compared with the 0-day, while there was a significant (P<0.05) increase in the second and third groups of treatment on the 5 th and 7 th day of treatment compared with the 0-day. The A/G ratio revealed a significant (P<0.05) decrease only in the first group of treatment on the 1 st day of treatment compared with the third group of treatment
The data presented in table 4 showed that serum calcium level showed a significant (P<0.05) increased from the 1 st day of treatment compared with 0-day in all groups of treatment. However serum phosphorus level was significantly (P<0.05) decreased from the 3 rd day of treatment in the first, second and third groups of treatment but from the 1 st day of treatment in the fourth group of treatment. Serum magnesium revealed a significant (P<0.05) increase from the 3 rd day of treatment in all treatment groups with nonsignificant changes between groups all over the period of treatment. The serum copper level revealed a significant (P<0.05) increase from the 3 rd day of treatment in all groups of treatment with only significant (P<0.05) on the 3 rd day of treatment in G1 and G1 and G4 compared with G2 and G3. Serum zinc level was revealed significantly (P<0.05) increased from the 3 rd day of treatment in G2, G3, and G4 but from the 5 th day of treatment in the G1 compared to the 0-day with non-significant changes between groups of treatment all over the period of treatment. 
DISCUSSION:
The major clinical signs of cats with NSHPT were anorexia, lameness, and irregularity of the vertebral column and long bones. Most of these cats referred with pathological fractures and a reluctance to move, posterior lameness, and in coordinated gait. Affected kittens developed constipation, tremor, muscle twitching, seizures and ataxic gait. Pain was observed due to nerve root compression related to NSHPT. Treatment was limited to short-term parenteral calcium gluconate injections, Catablets orally, to induce quick clinical recovery of cats with NSHPT. The marked improvement in clinical signs about 70-75% after the first dose of treatment with the first protocol of treatment (Ca and Vit D inj.). This result was comparable with the result of treatment of NSHPT recorded by Tomsa et al. (1999) who observed disappearance of clinical signs in cats 1-3 days post injection. On the other hand, treatment with second, third and fourth protocols improve in clinical signs after the third dose of treatment.
Biochemically, serum parathyroid hormone (PTH) and 1.25 (OH) Vit.D3 were significantly decreased from the 1 st day of treatment in all groups of treatment with only significant decrease in the first group of treatment (BP1) than the other three groups with non-significant changes between groups on the other periods of treatment. These results are nearly similar with Tomsa et al., (1999) , Nagata and Yuki (2013) and Parker et al., (2015) .The decrease of PTH level after treatment could be attributed to the rapid response of PTH secretions to changes in serum calcium. Once sufficient calcium source if given, serum ionized calcium normalized and PTH secretion drop rapidly and this result agreed with (Barber et al.,1993) who had similar results. In this study, the eggshell produced comparable results in terms of the level of PTH compared to the other conventional treatment.
Serum 25 (OH) Vit.D3 revealed significant increase from the 1 st day of treatment in all groups. This result agreed with Tomsa et al.(1999) and Parker et al.(2015) .This result may be attributed to increased blood level of calcium related Ca supplementation, increased Vit.D3 content of the diets for these cats and decreased hydroxylation of 25(OH) Vitamin D3 to 1,25(OH)2Vitamin.
Serum CPK activity was significantly decreased from the 1 st day of treatment in all groups of treatment with non-significant changes between groups. This result agreed with Nagata and Yuki (2013) . The CPK is an enzymatic marker for muscular damage secondary to NHPT and its reduction following treatment could be attributed to decreased skeletal muscles damages (Aroch et al (2010) , Watanabe and Duque (2011) and Nagata and Yuki ., 2013) .
However, serum ALP activity revealed a significant gradual decrease from the 1 st day of treatment in all groups of treatment with non-significant changes between them all over the period of treatment. The activity of serum alkaline phosphatase (ALP) was higher in affected cats with NSHPT, under the effect of high levels of PTH, P and low calcium level ,after treatment , the level of PTH ,P and calcium were corrected and within normal level states, so the ALP decreased Moarrabi et al (2008) .
Serum BUN revealed a significant gradual decreased from the 1 st day of treatment in all groups of treatment. On the other hand, the serum creatinine also gradually increased near the normal range from the 1 st day of treatment in all groups of treatment (Table, 2 ). This result agreed with Samra (2012) and Nagata and Yuki (2013) . This result could be attributed to the improvement of liver and kidney function, the PTH and P, Ca ratio due to offering balanced prepared cats food and medicated drugs in addition to decrease of bone pain and stress so cats can easily move and eat much. Serum total protein gradually increased began the 3 rd day of treatment in all groups of treatment with non-significant changes between them all over the period of treatment. On the other hand, serum albumin gradually increased from the 3 rd day of treatment in the first group of treatment (G1) but from the 1 st day of treatment in the other groups of treatment (G1, G2 and G3). The serum globulin increased in the first and fourth groups of treatment (G1 and G4) from the 1 st to 7 th day of treatment compared with the 0day, and from the 5 th and 7 th day in the second and third groups of treatment compared with the 0-day. These results agreed with Herz and Kirberger (2004) and Nagata and Yuki (2013) . This result could be attributed to the improvements of diet, liver, kidney function and protein metabolism and decreased inflammation of joint and bones that was decreased stress and pain so increase willing and ability of cats to move and eat much.
Calcium level revealed a significant increased from the 1 st day of treatment compared with 0-day in all groups of treatment. This result agreed with Moarrabi et al. (2008 ), Dimopoulou et al., (2010 , Mackenzie et al (2011) , Pineda et al(2012) , and Nagata and Yuki (2013) .This result could be attributed to the increase calcium intake, improvement of albumin level that results in increased calcium level, and balanced diet the cat received with the treatment. On the other hand, phosphorus level was gradually decreased beginning from the 3 rd day of treatment in the first, second and third groups of treatment (G1, G2 and G3) but began from the 1 st day of treatment in the fourth group of treatment (G4). This result agreed with Moarrabi et al. (2008) , Mackenzie et al. (2011 ), Pineda et al. (2012 , Nagata and Yuki (2013) . This result could be attributed to decreased phosphorus intake by offering balanced diet and the increased calcium intake(calcium preparation) in the 4 treatment groups.
Magnesium level revealed significant increase from the 3 rd day of treatment in all treatment groups with no significant changes between treatment groups all over the period of treatment. This result agreed with Robert and Rude (1998) . This result could be attributed to decreased Mg urinary excretion, cessation of mobilization of Mg from bone and increased Mg dietary source. It could also be attributed to decreased PTH because of some metabolic studies shoe a negative Mg balance I in hyperparathyroidism. On the other hand, the copper level was significantly increased from the 3 rd day of treatment in all groups of treatment with. Similarly, zinc level revealed significant increase from the 3 rd day of treatment in the second, third and fourth groups of treatment but from the 5 th day of treatment in the first group of treatment) compared with the 0-day with non-significant changes between groups of treatment all over the period of treatment. This result agreed with Robert and Rude (1998) , Strain(2004) . This result could be attributed to decreased Cu and Zn urinary excretion and increased Cu and Zn dietary source via the balanced diet.
CONCLUSION:
Based upon the results of this work, we can conclude that NSHPT can be induced in cats that fed mainly meat diets. Advanced cases with severe skeletal deformities and multiple fractures can be difficult to restore, but cases presenting mainly with pain, lameness and minor fractures respond well to dietary therapy when properly applied. While there are many protocols for treatment of NSHPT in kittens, the provision of balanced diet s and cage rest remains the first key of treatment of NSHPT in cats. The calcium supplementation is an essential part of treatment in addition to correction of the diet by a high-quality commercial food. Eggshell powder can be used as an alternative natural therapeutic preparation in small kittens to cure the progressive bone diseases secondary to NSHPT. 
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